Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its... see more

TSXV:THRM - Post Discussion

Therma Bright Inc > "Strategic Review"
View:
Post by dmshediac on Jun 21, 2024 7:20am

"Strategic Review"

looks like he plan's on doing something with Vemowave, Inretio and or InStatin,, sell them off or spin them out as separate co.'s.  , Reseach and development ,  hopefully some good "development,  permant codes,, successfull development in Inretio,, etc, who knows, but some development news should be comimg JMO
Comment by hk1966 on Jun 21, 2024 8:17am
Perhaps but would prefer he find a way to sell off non performing legacy assets like InterceptCS and Therozap and keep the newer investments like Instatin and Inretio. 
Comment by dmshediac on Jun 21, 2024 8:29am
i agree, clean up the non performing assets. Maybe Venowave will be a little good cash cow with sales , finally some regular revenue stream for the company. Keep it and sell the rest??? who knows, but we should get some knews soon, jmo
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities